Particularly high levels of expression (~90%) of the G-CSFR have been reported in human gastric and colon cancers, a setting in which G-CSF originates not only from tumor cells per se, but also from stromal myofibroblasts/fibroblasts in the tumor microenvironment (TME) [80]. This evidence concerns the gene CSF3 and neoplasm.